Skip to main content
OpenTrials
Completed

NCT Number: NCT03949010

Investigation of the Effectiveness of Muscle Inhibition and Space Correction Techniques of Kinesiotaping Method in Female Patients With Myofascial Pain Syndrome Related to Upper Trapezius Active Trigger Points

To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine the advantage of each technique over another.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP) Muscular Diseases Musculoskeletal Diseases Myofascial Pain Syndromes

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

The investigators conducted a prospective, randomized, controlled trial involving 93 female patients with MPS related to upper trapezius TPs and randomized the patients to KT treatment group with space correction technique and home exercise program (KSCT, n=20), KT treatment group with muscle inhibition technique and home exercise program (KMIT, n=24) and control group (CG, n=27) which received home exercise program only. Patients were evaluated by numerical rating scale (NRS) for their average and maximum pain intensity, Turkish version of neck disability index (NDI), and short form-36 (SF-36) scales. Statistical tests were conducted at the 0.05 significance level for all outcome measures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • being female
  • being aged between 18 and 45 years old
  • not being in menopausal period
  • having pain in upper trapezius region
  • determining a taut band in examination
  • having at least one active TP in this taut band
  • the pain produced by palpation of this TP is the pain that the patient complains
  • painfull restriction of cervical lateral flexion
  • having pain score 4 or more according to NRS
  • signing informed consent.

Exclusion criteria

  • having major surgery or trauma related to the musculoskeletal system (primarily including the spine and upper extremity)
  • having any operative history including the head and neck region
  • having a neuromuscular disease
  • having an active rheumatic disease
  • having a systemic disease (diabetes, hypothyroidism, infection, malignancy...)
  • having any pathology related to musculoskeletal diseases -especially including the cervical region- (cervical discopathy, cervical spondylosis, pathologies related to shoulder joint and surrounding soft tissues, scoliosis, kyphosis, limb length discrepancy, polio sequelae, developmental hip dysplasia...)
  • having serious psychological problems (having score of 30 or more from Beck Depression Inventory)
  • being obese (Body Mass Index≥30 kg/m2)
  • having allergy to kinesiotapes

Treatment and study plan

Kinesiotaping with space correction technique

Other

Kinesiotaping with space correction technique twice per week for two weeks along with home exercise program

Kinesiotaping with muscle inhibition technique

Other

Kinesiotaping with muscle inhibition technique twice per week for two weeks along with home exercise program

Home exercise program

Other

Home exercise program which consists of stretching exercises towards neck area

Primary outcomes

  1. Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks

    Time frame: Initial assessment, First week, second week, sixth week

    Pain intensity mesaurement via Numerical Rating Scale, range between 0 to 10, higher scores indicating more pain intensity

  2. Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

    Time frame: Initial assessment, second week, sixth week

    Functional status measurement via Neck Disability Index

  3. Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

    Time frame: Initial assessment, second week, sixth week

    Quality of life measurement via Short Form-36

Sponsors and collaborators

Lead sponsor

Dilşad Sindel

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
May 14, 2019
Registry last updated
May 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.